Author details

Full Name

Colin S Cooper

Affiliation

Norwich Medical School, University of East Anglia

ORCID

Career Start Year

1978

Papers

226

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36765747	Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer.	Cancers (Basel)	2023
37555750	Caution regarding the specificities of pan-cancer microbial structure.	Microb Genom	2023
37577699	Major data analysis errors invalidate cancer microbiome findings.	bioRxiv	2023
36661662	Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis.	Curr Oncol	2022
35454901	A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data.	Cancers (Basel)	2022
35659150	Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.	Eur Urol	2022
35450835	Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups.	Eur Urol Oncol	2022
34141535	Arthroscopic "Wallow" Procedure for Resection of Symptomatic Os Acromiale Pseudoarthrosis.	Arthrosc Tech	2021
33925381	Integration of Urinary EN2 Protein & Cell-Free RNA Data in the Development of a Multivariable Risk Model for the Detection of Prostate Cancer Prior to Biopsy.	Cancers (Basel)	2021
33727521	Factors Associated With Failure of Superior Pubic Ramus Screws.	J Orthop Trauma	2021
32203215	A novel stratification framework for predicting outcome in patients with prostate cancer.	Br J Cancer	2020
31779479	Methodology for the at-home collection of urine samples for prostate cancer detection.	Biotechniques	2020
32708551	Convergence of Prognostic Gene Signatures Suggests Underlying Mechanisms of Human Prostate Cancer Progression.	Genes (Basel)	2020
32153047	Development of a multivariable risk model integrating urinary cell DNA methylation and cell-free RNA data for the detection of significant prostate cancer.	Prostate	2020
31106513	A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.	BJU Int	2019
32055707	Potential for diagnosis of infectious disease from the 100,000 Genomes Project Metagenomic Dataset: Recommendations for reporting results.	Wellcome Open Res	2019
31639030	SEPATH: benchmarking the search for pathogens in human tissue whole genome sequence data leads to template pipelines.	Genome Biol	2019
30982861	Transcriptional changes in prostate of men on active surveillance after a 12-mo glucoraphanin-rich broccoli intervention-results from the Effect of Sulforaphane on prostate CAncer PrEvention (ESCAPE) randomized controlled trial.	Am J Clin Nutr	2019
30801051	epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer.	JCO Precis Oncol	2019
28753852	DESNT: A Poor Prognosis Category of Human Prostate Cancer.	Eur Urol Focus	2018
30132086	ORIF versus arthroplasty for open proximal humerus fractures: Nationwide Inpatient Sample data between 1998 and 2013.	J Orthop Traumatol	2018
30470249	A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.	Clin Epigenetics	2018
29662167	Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.	Nat Genet	2018
28698647	Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer.	Sci Rep	2017
28292578	Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144].	EBioMedicine	2017
28419548	Detection of prostate cancer-specific transcripts in extracellular vesicles isolated from post-DRE urine.	Prostate	2017
28945760	Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.	PLoS Genet	2017
27197245	Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.	Genome Res	2016
26455355	Prostate Single Nucleotide Polymorphism Provides a Crucial Clue to Cancer Aggression in Active Surveillance Patients.	Eur Urol	2016
26471473	Immunocytochemical detection of ERG expression in exfoliated urinary cells identifies with high specificity patients with prostate cancer.	BJU Int	2016
27798103	Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.	Hum Mol Genet	2016
25560400	HES5 silencing is an early and recurrent change in prostate tumourigenesis.	Endocr Relat Cancer	2015
26501111	Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.	EBioMedicine	2015
26609512	Pedicle Reduction Osteotomy in the Upper Cervical Spine: Technique, Case Report and Review of the Literature.	Int J Spine Surg	2015
26162314	Building Data-Driven Pathways From Routinely Collected Hospital Data: A Case Study on Prostate Cancer.	JMIR Med Inform	2015
25830880	The evolutionary history of lethal metastatic prostate cancer.	Nature	2015
26018901	Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.	Nat Genet	2015
25963125	Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.	Genome Res	2015
26005866	Spatial genomic heterogeneity within localized, multifocal prostate cancer.	Nat Genet	2015
25730763	Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.	Nat Genet	2015
25586381	Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing.	J Clin Pathol	2015
24481405	Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer.	Br J Cancer	2014
25456371	Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.	Lancet Oncol	2014
25271376	Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer.	Elife	2014
25297811	Benzo pyrene-induced DNA adducts and gene expression profiles in target and non-target organs for carcinogenesis in mice.	BMC Genomics	2014
25082706	Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.	Science	2014
23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Hum Mol Genet	2013
23695019	Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer.	Br J Cancer	2013
23774836	The present and future of prostate cancer urine biomarkers.	Int J Mol Sci	2013
23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Nat Genet	2013

1 - 50 of 226

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1997

Number of shared co-authors 9

Agnes Viale

Memorial Sloan Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 23

Alexei Protopopov

The University of MD Anderson Cancer Center

Career Start Year 1995

Number of shared co-authors 22

Volker Jung

Clinic of Urology and Pediatric Urology, University of Saarland

Career Start Year 1994

Number of shared co-authors 0

Arul M Chinnaiyan

University of Michigan Medical School.

Career Start Year 1993

Number of shared co-authors 43

Otavia L Caballero

Ludwig Institute for Cancer Research Ltd.

Career Start Year 1993

Number of shared co-authors 1

Teresa L Johnson-Pais

University of Texas Health San Antonio

Career Start Year 1990

Number of shared co-authors 3

Nallasivam Palanisamy

Vattikuti Urology Institute

Career Start Year 1990

Number of shared co-authors 10

Juha Kononen

Central Finland Hospital Nova

Career Start Year 1990

Number of shared co-authors 4

Abdel G Elkahloun

National Human Genome Research Institute

Career Start Year 1990

Number of shared co-authors 10

Thomas J Giordano

University of Michigan ann arbor

Career Start Year 1989

Number of shared co-authors 10

Adrie van Bokhoven

University of Colorado Anschutz Medical Campus

Career Start Year 1988

Number of shared co-authors 4

Mark A Watson

Washington University School of Medicine

Career Start Year 1987

Number of shared co-authors 5

Eivind Hovig

Center for Bioinformatics, University of Oslo

Career Start Year 1987

Number of shared co-authors 24

Olivier Delattre

PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie

Career Start Year 1987

Number of shared co-authors 21

Peter Lichter

German Cancer Research Center (DKFZ)

Career Start Year 1986

Number of shared co-authors 30

Ann M Killary

The University of Texas M. D. Anderson Cancer Center

Career Start Year 1984

Number of shared co-authors 2

Robin J Leach

University of Texas Health San Antonio

Career Start Year 1984

Number of shared co-authors 33

Olli Kallioniemi

Karolinska Institute

Career Start Year 1984

Number of shared co-authors 33

Alan Ashworth

UCSF Helen Diller Family Comprehensive Cancer Center

Career Start Year 1982

Number of shared co-authors 52

Edison T Liu

USA The Jackson Laboratory Cancer Center

Career Start Year 1982

Number of shared co-authors 7

David J Adams

Wellcome Sanger Institute

Career Start Year 1980

Number of shared co-authors 45

David M Thomas

Garvan Institute of Medical Research

Career Start Year 1980

Number of shared co-authors 21

Irene L Andrulis

University of Toronto

Career Start Year 1977

Number of shared co-authors 64

Webster K Cavenee

Ludwig Institute for Cancer Research, University of California San Diego

Career Start Year 1977

Number of shared co-authors 11

William E Grizzle

University of Alabama at Birmingham

Career Start Year 1974

Number of shared co-authors 1

Joe W Gray

Oregon Health and Science University

Career Start Year 1974

Number of shared co-authors 13

Raju Kucherlapati

Harvard Medical School

Career Start Year 1973

Number of shared co-authors 10

Paul S Meltzer

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1970

Number of shared co-authors 40

J. Carl Barrett

Oncology R&D

Career Start Year 1966

Number of shared co-authors 11

row(s) 1 - 30 of 30

Jeremy Clark

Norwich Medical School, University of East Anglia

Co-authored papers 67

Daniel S Brewer

University of Washington, USA Institute for Stem Cell and Regenerative Medicine

Co-authored papers 41

Rosalind A Eeles

The Institute of Cancer Research

Co-authored papers 40

Christopher S Foster

The Institute of Cancer Research

Co-authored papers 34

Sandra Edwards

The Institute of Cancer Research

Co-authored papers 25

Cyril Fisher

University Hospitals Birmingham NHS Foundation Trust

Co-authored papers 24

David E Neal

University of Oxford, John Radcliffe Hospital

Co-authored papers 23

Daniel M Berney

Barts Cancer Institute, Queen Mary University of London

Co-authored papers 21

Michael R Stratton

Wellcome Sanger Institute

Co-authored papers 21

Zsofia Kote-Jarai

The Institute of Cancer Research

Co-authored papers 19

Douglas F Easton

University of Cambridge

Co-authored papers 18

Alan Thompson

The Royal Marsden NHS Foundation Trust

Co-authored papers 17

Penny Flohr

The Institute of Cancer Research

Co-authored papers 17

Johann S de Bono

The Institute for Cancer Research

Co-authored papers 17

Gerhardt Attard

The Institute of Cancer Research

Co-authored papers 16

Hayley C Whitaker

University College London

Co-authored papers 13

Rachel Hurst

Seattle Children's Research Institute (K Liljenquist

Co-authored papers 13

Chris Ogden

The Royal Marsden Hospital NHS Foundation Trust

Co-authored papers 13

Yong-Jie Lu

Barts Cancer Institute, Queen Mary University of London

Co-authored papers 13

Vincent Khoo

The Royal Marsden NHS Foundation Trust and Institute of Cancer Research

Co-authored papers 12

Christopher J Woodhouse

Royal Marsden NHS Foundation Trust

Co-authored papers 12

Andy G Lynch

University of St Andrews

Co-authored papers 12

Anne Y Warren

Cambridge University Hospitals National Health Service Foundation Trust

Co-authored papers 12

Nening Dennis

Institute of Cancer Research

Co-authored papers 12

Charlie E Massie

University of Cambridge

Co-authored papers 11

Daniel Leongamornlert

Oncogenetics Team The Institute of Cancer Research London UK.

Co-authored papers 11

Ultan McDermott

Wellcome Sanger Institute

Co-authored papers 10

Freddie C Hamdy

University of Oxford

Co-authored papers 10

Victor E Reuter

Memorial Sloan Kettering Cancer Center

Co-authored papers 10

Adam Butler

Wellcome Sanger Institute

Co-authored papers 10

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators